Stock listing
KRYS Stock Price, News, Filings & Events — Krystal Biotech, Inc.
Selected listing: KRYS · NASDAQ · USD · US
This page tracks Krystal Biotech, Inc.'s KRYS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KRYS:NASDAQ. KRYS:NASDAQ is the stock-level entry point for investors researching Krystal Biotech, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Krystal Biotech, Inc. (ticker: KRYS) is a public company based in the United States with a market capitalization of approximately $10.78 billion. The company focuses on developing innovative gene therapies for various dermatological conditions. Krystal Biotech aims to address unmet medical needs through its proprietary technology platform.

- Ticker
- KRYS:NASDAQ
- Asset type
- Stock
- Market cap
- $10.78B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Krystal Biotech, Inc. KRYS:NASDAQ stock context
This page tracks Krystal Biotech, Inc.'s KRYS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KRYS:NASDAQ. KRYS:NASDAQ is the stock-level entry point for investors researching Krystal Biotech, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Krystal Biotech, Inc. (ticker: KRYS) is a public company based in the United States with a market capitalization of approximately $10.78 billion. The company focuses on developing innovative gene therapies for various dermatological conditions. Krystal Biotech aims to address unmet medical needs through its proprietary technology platform.
Research Krystal Biotech, Inc.
Krystal Biotech, Inc. investor report
Review AI stock analysis and investor report context for KRYS:NASDAQ.
Krystal Biotech, Inc. company profile
View the public company page for Krystal Biotech, Inc. on 6ix.
Krystal Biotech, Inc. news
Read company news and market updates connected to Krystal Biotech, Inc..
Krystal Biotech, Inc. investor events
Find investor webinars, events, and replay context for Krystal Biotech, Inc..
Alternate listings
4KB:GETTEX
DE · EUR
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
4KB:TRADEGATE
DE · EUR
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
A2JH2F:LSX
DE · EUR
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
A2JH2F:LS
DE · EUR
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
1KRYS:MIL
IT · EUR
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
KRYS:BOATS
US · USD
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
KRYS:BX
CH · CHF
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
K1YS34:BMFBOVESPA
BR · BRL
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
4KB:MUN
DE · EUR
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
4KB:SWB
DE · EUR
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
4KB:DUS
DE · EUR
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.
4KB:FWB
DE · EUR
Alternate listing for Krystal Biotech, Inc.; the primary context on this page is KRYS:NASDAQ.